Literature DB >> 34917759

The role of mass spectrometry in antibiotic stewardship.

Johannes Zander1,2, Michael Paal1, Michael Vogeser1.   

Abstract

•EU guidelines claim the need for widespread availability of TDM.•TDM of antibiotics is recognized as an important element of antibiotic stewardship.•However, availability of analytical services for antibiotic TDM is limited.•ID-LC-MS/MS instruments are still mainly restricted to centralized facilities.•Hospital laboratories should implement ID-LC-MS/MS for TDM of antibiotics.
© 2018 The Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL). Published by Elsevier B.V.

Entities:  

Year:  2018        PMID： 34917759      PMCID： PMC8669461          DOI： 10.1016/j.clinms.2018.11.001

Source DB:  PubMed          Journal:  Clin Mass Spectrom        ISSN： 2213-8005


  19 in total

1.  Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?

Authors:  Jason A Roberts; William W Hope; Jeffrey Lipman
Journal:  Int J Antimicrob Agents       Date:  2010-03-01       Impact factor: 5.283

2.  Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention.

Authors:  Loria A Pollack; Arjun Srinivasan
Journal:  Clin Infect Dis       Date:  2014-10-15       Impact factor: 9.079

3.  Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia.

Authors:  Robert E Ariano; Anna Nyhlén; J Peter Donnelly; Daniel S Sitar; Godfrey K M Harding; Sheryl A Zelenitsky
Journal:  Ann Pharmacother       Date:  2004-12-14       Impact factor: 3.154

4.  Quantification of vancomycin in human serum by LC-MS/MS.

Authors:  Katrin König; Uwe Kobold; Gerhard Fink; Andreas Leinenbach; Thomas Dülffer; Roland Thiele; Johannes Zander; Michael Vogeser
Journal:  Clin Chem Lab Med       Date:  2013-09       Impact factor: 3.694

5.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

6.  An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.

Authors:  Gloria Wong; Alexander Brinkman; Russell J Benefield; Mieke Carlier; Jan J De Waele; Najoua El Helali; Otto Frey; Stephan Harbarth; Angela Huttner; Brett McWhinney; Benoit Misset; Federico Pea; Judit Preisenberger; Michael S Roberts; Thomas A Robertson; Anka Roehr; Fekade Bruck Sime; Fabio Silvio Taccone; Jacobus P J Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  J Antimicrob Chemother       Date:  2014-01-16       Impact factor: 5.790

7.  An LC-MS/MS based candidate reference method for the quantification of total gentamicin in human serum and plasma using NMR characterized calibrator material.

Authors:  Stephanie Lucha; Judith Taibon; Stephan Pongratz; Christian Geletneky; Erasmus Huber; Christine Wintterle-Roehm; Robert Lang; Stefanie H Grimm; Thomas Duelffer; Kirill Tarasov; Johannes Zander; Michael Vogeser; Uwe Kobold
Journal:  Clin Chim Acta       Date:  2016-11-19       Impact factor: 3.786

8.  Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia.

Authors:  F Scaglione; S Esposito; S Leone; V Lucini; M Pannacci; L Ma; G L Drusano
Journal:  Eur Respir J       Date:  2009-02-12       Impact factor: 16.671

Review 9.  Novel antibiotics: are we still in the pre-post-antibiotic era?

Authors:  R Draenert; U Seybold; E Grützner; J R Bogner
Journal:  Infection       Date:  2015-02-21       Impact factor: 3.553

10.  Piperacillin concentration in relation to therapeutic range in critically ill patients--a prospective observational study.

Authors:  Johannes Zander; Gundula Döbbeler; Dorothea Nagel; Barbara Maier; Christina Scharf; Mikayil Huseyn-Zada; Jette Jung; Lorenz Frey; Michael Vogeser; Michael Zoller
Journal:  Crit Care       Date:  2016-04-04       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.